Week Ending August 23, 2021

WHO releases global guidance for HBV, HCV elimination
“WHO released the first-ever global guidance for countries seeking validated hepatitis B virus and hepatitis C virus elimination.”

Sofosbuvir/Velpatasvir – A Promising Treatment for Chronic Hepatitis C Virus Infection
“Hepatitis C virus (HCV) infection is a disease that affects millions of people worldwide and has an enormous global public health impact. Chronic HCV is a long-term infection that goes unnoticed until the virus destroys the liver enough to induce liver disease symptoms. The inadequate and poorly tolerated treatment contributes to the burden of chronic HCV.”

Hepatocellular carcinoma risk in hepatitis C stage-3 fibrosis after sustained virological response with direct-acting antivirals
“Except in males over 55 years old, the prevalence of primary liver tumours was minimal after sustained virological response and much below the threshold for cost-effectiveness of screening in a large, well-defined cohort of patients with baseline hepatitis C stage-3 fibrosis.”

Hepatitis C Eradication Linked to Lower Mortality in People With Mild Fibrosis
“Curing hepatitis C in people with mild liver fibrosis reduced the risk of death from liver-related and other causes, according to findings published in the Journal of Viral Hepatitis.”

Hepatitis C kidney transplant: Is it possible?
“Some people living with hepatitis C can receive a kidney transplant if their kidneys fail. These individuals can also donate a kidney if they are otherwise healthy and a doctor agrees that it is appropriate.”